JOINT FILING AGREEMENTJoint Filing Agreement • February 9th, 2024 • venBio Global Strategic Fund III, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 9th, 2024 Company IndustryThe undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of RayzeBio, Inc. dated as of February 9, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.